The MedTech M&A market has demonstrated remarkable resilience despite a period of macroeconomic uncertainty. However, the growth drivers of today look significantly different from those making waves during the pandemic era. A&M's Life Sciences team highlights trends, challenges, and strategies for the MedTech mergers and acquisitions (M&A) landscape, offering predictions for 2025 and beyond.
This report includes:
- Analysis of the shifting landscape of MedTech M&A in the post-pandemic era
- Strategic insights around how leading companies are leveraging M&A to drive competitive advantage
- Recommendations for both acquirers and targets
- Our predictions for M&A trends in the industry
Dive into the future of MedTech M&A and stay ahead of the curve in this rapidly evolving sector.
Download the Report
When Security Creates Scarcity: DSCSA’s Unintended Consequence
June 2, 2025
In a recent article, A&M Life Sciences experts discuss The Drug Supply Chain Security Act and how well-intentioned regulations may be straining the very system they’re meant to safeguard.
Medtech CDMOs in 2025: Perspectives on Activity in the Medtech CDMO Market
May 19, 2025
Driving the future of medical innovation, Medtech CDMOs are leveraging strategic M&A and advanced technologies to scale growth. Amid regulatory complexity, key players are accelerating development and meeting rising demand for specialized manufacturing.
Discover the Future of Connected Health
May 2, 2025
Dive into "The Seven Truths of Connected Health," our latest Life Sciences report that explores how connected health changes patient behavior at key decision points.
Elevating Customer Support in Healthcare
April 16, 2025
Customer service isn’t just about solving problems, it’s about shaping perception. In healthcare, where trust and clarity are essential, support teams are uniquely positioned to elevate the entire customer experience.
